IOL CHEMICALS & PHARM. | JENBURKT PH. | IOL CHEMICALS & PHARM./ JENBURKT PH. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.5 | 13.3 | 101.8% | View Chart |
P/BV | x | 1.5 | 2.7 | 58.0% | View Chart |
Dividend Yield | % | 1.0 | 2.0 | 51.7% |
IOL CHEMICALS & PHARM. JENBURKT PH. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
JENBURKT PH. Mar-23 |
IOL CHEMICALS & PHARM./ JENBURKT PH. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 760 | 70.6% | |
Low | Rs | 272 | 452 | 60.2% | |
Sales per share (Unadj.) | Rs | 377.6 | 310.1 | 121.8% | |
Earnings per share (Unadj.) | Rs | 23.7 | 55.8 | 42.5% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 60.9 | 51.8% | |
Dividends per share (Unadj.) | Rs | 4.00 | 14.40 | 27.8% | |
Avg Dividend yield | % | 1.0 | 2.4 | 41.6% | |
Book value per share (Unadj.) | Rs | 256.8 | 277.5 | 92.5% | |
Shares outstanding (eoy) | m | 58.71 | 4.41 | 1,331.3% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 2.0 | 54.8% | |
Avg P/E ratio | x | 17.1 | 10.9 | 157.0% | |
P/CF ratio (eoy) | x | 12.8 | 10.0 | 128.7% | |
Price / Book Value ratio | x | 1.6 | 2.2 | 72.1% | |
Dividend payout | % | 16.9 | 25.8 | 65.3% | |
Avg Mkt Cap | Rs m | 23,743 | 2,675 | 887.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 388 | 433.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 1,367 | 1,621.3% | |
Other income | Rs m | 256 | 51 | 499.9% | |
Total revenues | Rs m | 22,427 | 1,419 | 1,580.8% | |
Gross profit | Rs m | 2,257 | 304 | 743.1% | |
Depreciation | Rs m | 462 | 23 | 2,043.4% | |
Interest | Rs m | 165 | 4 | 4,487.7% | |
Profit before tax | Rs m | 1,887 | 329 | 574.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 83 | 599.5% | |
Profit after tax | Rs m | 1,391 | 246 | 565.4% | |
Gross profit margin | % | 10.2 | 22.2 | 45.8% | |
Effective tax rate | % | 26.2 | 25.1 | 104.5% | |
Net profit margin | % | 6.3 | 18.0 | 34.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 811 | 1,192.1% | |
Current liabilities | Rs m | 5,025 | 158 | 3,188.2% | |
Net working cap to sales | % | 20.9 | 47.8 | 43.8% | |
Current ratio | x | 1.9 | 5.1 | 37.4% | |
Inventory Days | Days | 43 | 130 | 33.2% | |
Debtors Days | Days | 8 | 453 | 1.8% | |
Net fixed assets | Rs m | 11,017 | 603 | 1,827.2% | |
Share capital | Rs m | 587 | 44 | 1,330.4% | |
"Free" reserves | Rs m | 14,490 | 1,180 | 1,228.2% | |
Net worth | Rs m | 15,077 | 1,224 | 1,231.9% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 1,414 | 1,462.9% | |
Interest coverage | x | 12.5 | 90.6 | 13.8% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 1.0 | 110.8% | |
Return on assets | % | 7.5 | 17.7 | 42.6% | |
Return on equity | % | 9.2 | 20.1 | 45.9% | |
Return on capital | % | 13.6 | 27.2 | 50.1% | |
Exports to sales | % | 26.7 | 18.5 | 144.8% | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | 253 | 2,347.8% | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 253 | 2,347.8% | |
Fx outflow | Rs m | 6,052 | 22 | 27,508.2% | |
Net fx | Rs m | -122 | 231 | -52.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 171 | 717.0% | |
From Investments | Rs m | -1,200 | 26 | -4,583.7% | |
From Financial Activity | Rs m | -41 | -210 | 19.5% | |
Net Cashflow | Rs m | -18 | -14 | 134.2% |
Indian Promoters | % | 48.2 | 33.3 | 144.8% | |
Foreign collaborators | % | 0.0 | 14.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 52.8 | 98.2% | |
Shareholders | 130,003 | 6,316 | 2,058.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | JENBURKT PH. | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.64% | -0.24% | -0.57% |
1-Month | 4.77% | 3.44% | 0.07% |
1-Year | -0.25% | 5.38% | 52.18% |
3-Year CAGR | -13.23% | 17.91% | 14.04% |
5-Year CAGR | 16.12% | 8.77% | 19.13% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the JENBURKT PH. share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of JENBURKT PH. the stake stands at 47.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of JENBURKT PH..
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
JENBURKT PH. paid Rs 14.4, and its dividend payout ratio stood at 25.8%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of JENBURKT PH..
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.